药物对比
Canagliflozin vs Gliquidone
比较Canagliflozin与Gliquidone治疗2型糖尿病。SGLT2抑制剂与磺脲类：机制、血糖控制、低血糖风险、体重、心血管获益及副作用。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when choosing add-on oral therapy for type 2 diabetes after metformin, weighing SGLT2 inhibitor benefits against sulfonylurea use.
结论
Canagliflozin typically offers more benefits beyond glucose lowering than Gliquidone, but the choice must be personalized.
全部药物对比